The FDA Process for Approving Generic Drugs
- ANDA data must prove a generic drug is scientifically bioequivalent to the original drug. The generic drug must contain the same active ingredients as the original drug and must be absorbed into the bloodstream at the same rate.
- Applications for generic drug approval do not require clinical data that proves the safety and efficacy of the drug, unlike applications for original drugs. This law, established by the Drug Price Competition and Patent Term Restoration Act of 1984, is designed to expedite generic drug availability by making applications less expensive.
- Generic drugs are less expensive than brand name drugs because their manufacturers do not research, advertise or market the drugs. They are not inferior in quality to brand name drugs, according to the FDA.
ANDA Facts
Features
Misconceptions
Source...